TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.19%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.8B
AUM Growth
+$2.8B
(+3.6%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
45.4%
Holding
164
New
19
Increased
21
Reduced
19
Closed
12
Top Buys
| 1 |
Gilead Sciences
GILD
|
$22M |
| 2 |
Thermo Fisher Scientific
TMO
|
$15.1M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13M |
| 4 |
Johnson & Johnson
JNJ
|
$11M |
| 5 |
Edwards Lifesciences
EW
|
$10.6M |
Top Sells
| 1 |
iShares Biotechnology ETF
IBB
|
$23.6M |
| 2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$12.8M |
| 3 |
Biogen
BIIB
|
$12.6M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Puma Biotechnology
PBYI
|
$11.6M |
Sector Composition
| 1 | Healthcare | 93.03% |
| 2 | Real Estate | 2.85% |
